IMUC
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
12.65M
PTCT
Price
$44.74
Change
-$1.58 (-3.41%)
Updated
Jul 25 closing price
Capitalization
3.55B
11 days until earnings call
Interact to see
Advertisement

IMUC vs PTCT

Header iconIMUC vs PTCT Comparison
Open Charts IMUC vs PTCTBanner chart's image
EOM Pharmaceutical Holdings
Price$0.10
Change-$0.00 (-0.00%)
Volume$2.15K
Capitalization12.65M
PTC Therapeutics
Price$44.74
Change-$1.58 (-3.41%)
Volume$1.29M
Capitalization3.55B
IMUC vs PTCT Comparison Chart in %
Loading...
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUC vs. PTCT commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUC is a StrongBuy and PTCT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IMUC: $0.10 vs. PTCT: $44.74)
Brand notoriety: IMUC and PTCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUC: 103% vs. PTCT: 129%
Market capitalization -- IMUC: $12.65M vs. PTCT: $3.55B
IMUC [@Biotechnology] is valued at $12.65M. PTCT’s [@Biotechnology] market capitalization is $3.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUC’s FA Score shows that 1 FA rating(s) are green whilePTCT’s FA Score has 1 green FA rating(s).

  • IMUC’s FA Score: 1 green, 4 red.
  • PTCT’s FA Score: 1 green, 4 red.
According to our system of comparison, PTCT is a better buy in the long-term than IMUC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUC’s TA Score shows that 4 TA indicator(s) are bullish while PTCT’s TA Score has 4 bullish TA indicator(s).

  • IMUC’s TA Score: 4 bullish, 3 bearish.
  • PTCT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMUC is a better buy in the short-term than PTCT.

Price Growth

IMUC (@Biotechnology) experienced а +25.00% price change this week, while PTCT (@Biotechnology) price change was -6.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

IMUC is expected to report earnings on Nov 20, 2024.

PTCT is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCT($3.55B) has a higher market cap than IMUC($12.7M). PTCT has higher P/E ratio than IMUC: PTCT (6.87) vs IMUC (0.02). PTCT YTD gains are higher at: -0.886 vs. IMUC (-40.758). PTCT has higher annual earnings (EBITDA): 839M vs. IMUC (-5.65M). PTCT has more cash in the bank: 2.03B vs. IMUC (85.3K). PTCT has higher revenues than IMUC: PTCT (1.77B) vs IMUC (0).
IMUCPTCTIMUC / PTCT
Capitalization12.7M3.55B0%
EBITDA-5.65M839M-1%
Gain YTD-40.758-0.8864,600%
P/E Ratio0.026.870%
Revenue01.77B-
Total Cash85.3K2.03B0%
Total DebtN/A390M-
FUNDAMENTALS RATINGS
IMUC vs PTCT: Fundamental Ratings
IMUC
PTCT
OUTLOOK RATING
1..100
3062
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8861
P/E GROWTH RATING
1..100
10029
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMUC's Valuation (9) in the Biotechnology industry is significantly better than the same rating for PTCT (99). This means that IMUC’s stock grew significantly faster than PTCT’s over the last 12 months.

IMUC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PTCT (100). This means that IMUC’s stock grew similarly to PTCT’s over the last 12 months.

IMUC's SMR Rating (100) in the Biotechnology industry is in the same range as PTCT (100). This means that IMUC’s stock grew similarly to PTCT’s over the last 12 months.

PTCT's Price Growth Rating (61) in the Biotechnology industry is in the same range as IMUC (88). This means that PTCT’s stock grew similarly to IMUC’s over the last 12 months.

PTCT's P/E Growth Rating (29) in the Biotechnology industry is significantly better than the same rating for IMUC (100). This means that PTCT’s stock grew significantly faster than IMUC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMUCPTCT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
60%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SQBIX14.510.04
+0.28%
X-Square Balanced Fund, LLC Instl
FLPKX44.770.09
+0.20%
Fidelity Low-Priced Stock K
TIRHX18.21-0.01
-0.05%
Nuveen Real Estate Sec Sel I
BCAIX36.48-0.08
-0.22%
Boston Common ESG Impact Intl
FANIX48.30-0.16
-0.33%
Fidelity Advisor Energy I

IMUC and

Correlation & Price change

A.I.dvisor tells us that IMUC and GRCE have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMUC and GRCE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUC
1D Price
Change %
IMUC100%
N/A
GRCE - IMUC
7%
Poorly correlated
-3.75%
TNXP - IMUC
6%
Poorly correlated
+9.24%
SRPT - IMUC
5%
Poorly correlated
-7.38%
ORMP - IMUC
5%
Poorly correlated
N/A
PTCT - IMUC
4%
Poorly correlated
-3.41%
More